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BACKGROUND: The HOXA10 homeobox gene controls embryonic uterine development and adult endometrial
receptivity. The three-amino-acid loop extension (TALE) family homeobox genes like myeloid ecotropic viral inte-
gration site 1 (MEIS) provide enhanced target gene activation and speciﬁcity in HOX-regulated cellular processes
by acting as HOX cofactors. METHODS AND RESULTS: Analysis of an Affymetrix data set in the public domain
showed high expression of MEIS1 in human endometrium. MEIS1 expression was conﬁrmed during the human men-
strual cycle by RT–PCR and in situ hybridization and was increased duringthe secretory comparedwith proliferative
phase of the cycle (P 5 0.0001), the time of implantation. To assess the importance of maternal Meis1 expression in a
mouse model, the uteri of Day 2 pregnant mice were injected with Meis1 over-expression or small interfering RNA
(siRNA) constructs. Blocking Meis1 expression by siRNA before implantation signiﬁcantly reduced average implan-
tation rates (P 5 0.00001). Increased or decreased Meis1 expression signiﬁcantly increased or decreased the
expression of integrin b3, a transcriptional target of HOXA10 and an important factor in early embryo-endometrium
interactions (P 5 0.006).ManipulatingMeis1expression before implantation also dramatically affectedthe number of
pinopodes, uterine endometrial epithelial projections that develop at the time of endometrial receptivity.
CONCLUSIONS: The results suggest that in mouse, meis1 contributes to regulating endometrial development
during the menstrual cycle and establishing the conditions necessary for implantation.
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Introduction
The molecular mechanisms responsible for endometrial devel-
opment and receptivity to embryonic implantation are poorly
understood (Cross et al., 1994; Wang and Dey, 2006). In the
last few years, therefore, a large number of high-throughput
expression proﬁling studies have been performed on both
human and animal model tissues to identify the molecular sig-
naling involved in the endometrial development and
embryo-endometrium interactions leading to successful
embryonic implantation. These include DNA-microarray
studies (reviewed in Horcajadas et al., 2007; see also Chen
et al., 2006; Pan et al., 2006), as well as SAGE (serial analysis
of gene expression) studies (Blomberg et al., 2005; Ma et al.,
2006). In addition, two databases have been set up that
contain expression data on genes thought to be involved in
endometrium development and function: www.endometrialda-
tabase.com and endometrium.bcm.tmc.edu.
HOX-class homeobox genes are leading candidates for the
regulation of endometrium differentiation in preparation for
embryonic implantation (Taylor, 2000a; Eun Kwon and
Taylor, 2004). HOX genes assign the correct identity to undif-
ferentiated body segments along several developmental axes
(Krumlauf, 1994; Carroll, 1995; Moens and Selleri, 2006;
Wellik, 2007; Zakany and Duboule, 2007). They are,
however, not only typically expressed during embryogenesis
but also persistently active in both the mouse and human
female reproductive tract (Taylor et al., 1997; Taylor,
2000b). The continued expression of these HOX genes
allows the reproductive tract to maintain developmental plas-
ticity and to differentiate appropriately during each menstrual
cycle and throughout pregnancy. †These authors contributed equally to this study.
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Advance Access publication on April 12, 2008The development of the para-mesonephric duct in the
embryo is dictated in part by the abdominal-B group of HOX
genes (Taylor et al., 1997, 1998; Taylor 2000b; Eun Kwon
and Taylor, 2004). Speciﬁcally, HOXA10 is responsible for
proper uterine development in both mouse and man (Taylor
et al., 1997; Block et al., 2000). Female Hoxa10 null-mutant
mice demonstrate uterine factor infertility (Satokata et al.,
1995). These mice ovulate normally and produce normal
embryos, but their uteri will not support the implantation of
their own or transplanted wild-type embryos. In humans,
HOXA10 expression is up-regulated in the mid-luteal phase
at the time of implantation, and its expression is driven by
estrogen and progesterone (Taylor et al., 1998). HOXA10 is
a well-characterized marker of endometrial receptivity, which
exerts pleiotropic effects on multiple aspects of adult endo-
metrial development such as stromal decidualization, leuko-
cyte inﬁltration and pinopode development (Bagot et al.,
2001; Daftary and Taylor, 2004; Qian et al., 2005).
Pinopodes (also called uterodomes) are the
best-characterized structural markers of endometrial receptiv-
ity in rodents and humans (Nikas, 2000; Nardo et al., 2002;
Nikas and Makrigiannakis, 2003). Defective endometrial
HOXA10 expression has been described in several conditions
that result in diminished human embryo implantation such as
endometriosis, polycystic ovarian syndrome, and hydrosalpinx
ﬂuid (Taylor et al., 1999; Daftary and Taylor 2002; Cermik
et al., 2003). One of the known downstream target genes of
Hoxa10 in endometrial cells is Itgb3 (Daftary et al., 2002).
HOX genes perform their function by acting as transcription
factors. They bind to the regulatory regions of downstream
target genes through their homeobox domain, and thereby acti-
vate or repress transcription. HOX proteins bind only weakly to
DNA by themselves and/or exhibit a high degree of redun-
dancy in binding site speciﬁcity (Pellerin et al., 1994). It has
become increasingly evident that HOX proteins usually act
as a part of hetero-dimeric (van Dijk et al., 1995; Kurant
et al., 1998) or hetero-trimeric complexes (Jacobs et al.,
1999; Shen et al., 1999; Schnabel et al., 2000). The TALE
(three-amino-acid loop extension) family of homeodomain
proteins represents the most important group of HOX cofac-
tors. The unique TALE motif within their homeodomain
allows TALE proteins to interact with other homeobox-
containing proteins (Bu ¨rglin, 1997; Piper et al., 1999).
Unlike most other homeobox gene families, TALE genes
share sequence homology outside of the homeobox domain.
This extensive homology appears linked to their function.
Single TALE proteins have only low DNA-binding activity
and speciﬁcity, but once complexed with a TALE protein
from another subfamily and a HOX-class homeobox protein
via these homologous domains, they show powerful and
speciﬁc downstream target promoter regulation (reviewed in
Geerts et al., 2003, 2005). Abd-B-like HOX transcription
factors, like HOXA10, can form dimers or trimers with
TALE proteins that thereby regulate the multiple HOX down-
stream target genes necessary for the implantation process.
The myeloid ecotropic viral integration site 1 (MEIS) genes
belong to the TALE homeobox family. MEIS proteins are not
just involved in TALE complex DNA binding and complex
stabilization on the target DNA, but can also recruit other
TALE partner proteins into the nucleus (Rieckhof et al.,
1997). Meis1 was ﬁrst identiﬁed as a major integration site
for leukemogenic virus in a murine leukemia model
(Moskow et al., 1995). Also in human leukemia, high
expression of MEIS1 was found in bone marrow cells of
acute myelogenous leukemia (AML) patients, where it was
always co-expressed with HOXA9 (Smith et al., 1997; Lawr-
ence et al., 1999). HOXA9 expression was found to cause
transformation of normal hematopoietic cells to AML cells
only when expressed together with MEIS1 (Kroon et al.,
1998). Speciﬁcally, MEIS1 expression is vital for keeping
HOXA9-immortalized myeloid cells in an undifferentiated,
proliferating state, refractory to granulocyte-colony stimulat-
ing factor-induced terminal differentiation (Calvo et al., 2001).
Though co-expression and interaction of MEIS1 with
Abd-B-like HOX transcription factors was convincingly
demonstrated in leukemia, the data on MEIS1 gene expression
and function in the endometrium were still scarce. In the
current study, we performed data-mining on gene expression
sets in the public domain to investigate the expression of the
MEIS genes (MEIS1–3) in the human female reproductive
tract. We next characterized the menstrual cycle-speciﬁc
pattern of MEIS1 in human endometrium. To block or over-
express maternal Meis1 expression with Meis1 small interfer-
ing RNA (siRNA) or over-expression constructs in a mouse
model, we used liposome-mediated gene transfection in the
murine uterus, to investigate whether maternal Meis1
expression in the endometrium contributes to implantation.
We conclude from these experiments that manipulation of
adult Meis1 expression signiﬁcantly affected fertility in the
mouse.
Materials and Methods
Meis gene expression in normal tissue
Affymetrix data for a set of 87 different normal human tissue types
(the ‘human body index’ set) representing a total of 504 tissue
samples were retrieved from public gene expression omnibus (GEO)
data sets on the National Center for Biotechnology Information
(NCBI) website (Barrett et al., 2005, 2007). CEL data from the Affy-
metrix GeneChip Human Genome U133 Plus 2.0 array data sets were
downloaded, and intensity values and the accompanying P-values
assigned with GeneChip
w Operating Software (GCOS) using the
MASS5.0 algorithm (Affymetrix, Santa Barbara, CA, USA). Annota-
tions and clinical data for the tissue samples analyzed were available
from http://www.ncbi.nlm.nih.gov/geo/query/ through its GEO ID:
GSE7303.
Human tissue collection
Endometrial tissue was collected during routine endometrial biopsy
from women with a normal menstrual cycle who were eligible for
IVF and embryo transfer because of (partial) tubal blockage. Informed
consent was obtained from all patients. The tissue collection met with
the conditions described in the ‘Declaration of Helsinki for Medical
Research involving Human Subjects’ as described in (http://www.
wma.net/e/plicy/pdf/17c/pdf). Also, approval was obtained from
the Tongji Hospital research and ethics committee. One half of the
tissue sample was immediately frozen in liquid nitrogen and stored
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sectioned and stained with hematoxylin and eosin. Menstrual cycle
dating was determined by menstrual history and conﬁrmed by histo-
logical examination using the Noyes criteria (Noyes et al., 1955).
The early and late proliferative phase, and the early, mid and late
secretory phase were deﬁned as Days 5–9, 10–14, 15–19, 20–24
and 25–28 of the menstrual cycle, respectively.
RNA isolation and RT–PCR
Total RNA was extracted using the total RNA isolation reagent (TRI
reagent, Molecular Research Center, Cincinnati, OH, USA) according
to the manufacturer’s instructions. Four microgram total RNA from
each sample was denatured at 708C for 5 min and chilled rapidly on
ice. The RNA was then reverse transcribed in a 20 ml reaction
mixture containing 4 ml5   RT buffer, 2 ml 10 mM dNTP, 1 ml
0.5 mg/ml Oligo(dT15), 0.5 ml5 0U /ml ribonuclease inhibitor, 1 ml
200 U/ml Moloney murine leukemia virus transcriptase (Promega,
Madison, WI, USA) with the following reaction condition: 428C for
60 min; 958C for 5 min in a Biometra T Gradient Thermocyler (Bio-
metra, Go ¨ttingen, Germany). After ﬁrst strand complementary DNA
(cDNA) synthesis, 2 ml of cDNA was ampliﬁed in 50 ml of PCR
mixture containing 5 ml1 0  PCR buffer, 4 ml 25 mM MgCl2,1ml
10 mM dNTP, 1.5 ml( 1U /ml) Taq polymerase (Fermentas, Foster
City, CA, USA) and 1 ml (10 pmol/ml) of each primer pair. The
primers used were (forward, reverse): for human MEIS1
(50-TCCATAGCTCTTCACTTC-30,5 0-GCTTGATGTGACAATT
AG-30), for mouse Meis1 (50-ACGGCATCCACTCGTTCA-30,
50-TGGCTGTCCATCAGGGTT-30), for mouse integrin b3 (Itgb3)
(50-GCCTTCGTGGACAAGCCTGTA-30,5 0-GGACAATGCCTGCC
AGTCTTC-30), for human Glyceraldehyde-3-phosphate dehydrogen-
ase (GAPDH) (50-GGTCGGAGTCAACGGATTTGGTCG-30,5 0-CT
TCCGACGCCTGCTTCACCAC-30) and for mouse b-actin (50-
TTCCAGCCTTCCTTCTTGGG-30,5 0-TTGCGCTCAGGAGGAG
CAAT-30). The PCR reactions were performed as follows: 948C for
5 min, followed by a number of cycles of 948C for 40 s, annealing
for 50 s at different annealing temperatures, and 728C for 1 min, fol-
lowed by incubation at 728C for 10 min. Annealing temperatures for
human MEIS1, mouse Meis1, mouse Itgb3, mouse b-actin and
human GAPDH were 558C, 508C, 558C, 508C, and 558C, respectively,
and the numbers of cycles were 25, 30, 28, 30 and 25, respectively.
The PCR products were separated on 2% agarose gels and visualized
by ethidium bromide (EtBr) staining under UV light. The resulting
PCR products were 411 bp for human MEIS1 [representing nucleo-
tides (nt) 2261–2671 of RefSeq NM_002398), 405 bp for mouse
Meis1 (nt 1106–1510 of NM_010789), 337 bp for mouse Itgb3 (nt
571–907 of NM_016780), 786 bp for human GAPDH (nt 117–902
of NM_002046) and 224 bp for mouse b-actin (nt 850–1073 of
NM_007393). Mouse Meis1 primers used in the experiments
described yielded a 405 bp PCR product containing endogenous
mouse Meis1 as well as human MEIS1 (nt 1115–1519 of
NM_002398), resulting from the pcDNA4-encoded transgene.
Human MEIS1 or mouse Meis1 and Itgb3 mRNA levels were calcu-
lated as a ratio of the densitometric values for MEIS1, Meis1, or
Itgb3 to their corresponding GAPDH or b-actin values. Care was
taken to ensure a logarithmic signal for the PCR products measured.
RT–PCR reactions performed for human MEIS1/GAPDH showed
differential MEIS1 and equal GAPDH expression for all samples
when RT–PCR was performed for 28, 25 or 22 cycles. For all three
cycle numbers used, MEIS1 and GAPDH signal intensities were
different between cycle numbers. Similar results were obtained for
mouse Meis1/b-actin (35, 30 or 25 cycles) and mouse itgb3/b-actin
(30, 28 or 25 cycles) (results not shown).
In situ hybridization
Diethyl pyrocarbonate-treated Milli-Q water was used in each step.
Sections (4 mm thick) were immersed in 30% H2O2 solution for
30 min to eliminate endogenous peroxidase activity. After rinsing in
100 mM phosphate-buffered saline (PBS), sections were treated
withpepsin [0.02% (w/v) in 3% citric acid] at 378C for 10 min. There-
after, sections were ﬁxed in freshly prepared 4% (w/v) paraformalde-
hyde in PBS for 20 min at 48C, rinsed in PBS and immersed in 0.25%
acetic anhydride, 100 mM triethanolamine and 0.9% (w/v) NaCl con-
secutively, each for 10 min at room temperature. The probe for human
MEIS1 was a 1:1 molar mixture of single stranded DNA oligonucleo-
tides complementary to the 50-CACTCGCATCAGTACCCGCA
CACAGCTCATACCAA-30 (nt 593–627 of NM_002398) and
50-ACACCTTATAATCCTGATGGACAGCCCATGGGAGG-30 (nt
1493–1527 of NM_002398) MEIS1 sequences, labeled with digoxi-
genin. Sections were hybridized overnight at 408C in hybridization
buffer containing digoxigenin-labeled oligonucleotide probe at a
ﬁnal concentration of 400 mg/l. After hybridization, sections were
washed in fresh 2   SSC (saline sodium citrate) at 378C for 10 min,
0.5   SSC at 378C for 15 min, and 0.2   SSC at 378C for 15 min,
then incubated in 5% (w/v) bovine serum albumin for 30 min at
room temperature, and in biotin-anti-digoxigenin at 378C for 1 h,
and ﬁnally washed and incubated in streptavidin–biotin complex
(SABC) for 20 min at 378C. Probe labeling, and digoxigenin,
biotin-anti-digoxigenin and SABC incubations were performed
using the MK2502 kit (Boster Bio-technology, Wuhan, Hubei,
China). The brown precipitate generated at the site of
digoxigenin-probe hybridization by reaction of the anti-digoxigenin
antibody bound peroxidase with diaminobenzidine tetrahydrochloride
(DAB) (AR1022, Boster Bio-technology) was scored as presence of
MEIS1 mRNA. Hematoxylin was used for counterstaining. A total
of 33 samples were examined. The staining of 100 consecutive cells
in ﬁve non-adjacent microscopic ﬁelds was evaluated to quantify the
expression of MEIS1.
Western blot analysis
Tissues from each mouse uterus were washed twice with PBS and
lysed on ice in lysis buffer [50 mM Tris–HCl (pH 8.0), 150 mM
NaCl, 0.1% (w/v) sodium dodecyl sulfate (SDS), 0.5% (w/v)
sodium deoxycholate, 1% (v/v) Nonidet-P40, 0.02% (w/v) sodium
azide and freshly added protease inhibitors (phenylmethylsulphonyl
ﬂuoride to 10 mg/ml and aprotinin to 1 mg/ml)]. Solid cellular
debris was removed by centrifugation at 1200g for 5 min. Protein con-
centration was measured by the Coomassie Brilliant Blue G-250
assay. Protein samples (45 mg each) were subjected to 10% SDS–
polyacrylamide gel electrophoresis and transferred onto polyvinyli-
dene diﬂuoride membrane using a Bio-Rad electroblot apparatus
(Bio-Rad, Beijing, China). Non-speciﬁc binding sites were blocked
in 5% (w/v) non-fat dry milk in PBS containing 0.05% (v/v)
Tween-20. The primary goat anti-MEIS1 polyclonal antibody
(sc-10599, Santa Cruz, CA, USA) was used at 1:100 and incubated
at 48C overnight. This antibody was raised against a C-terminal
epitope of human MEIS1, and recognizes both human MEIS1 and
murine Meis1, since their protein sequences are identical in that
region (also see below, section MEIS1 constructs). As secondary anti-
body rabbit peroxidase-conjugated anti-goat immunoglobulin (Ig)G
(ZDR-5308, Zhongshan Biotechnology, Beijing, China) was used at
1:200, and incubated at 378C for 1.5 h. Rabbit anti-actin antibody
(sc-101616-R, Zhongshan Biotechnology, as a loading control) was
used at 1:500 and incubated at 48C overnight, and the secondary anti-
body goat anti-rabbit IgG (ZDR-5306, Zhongshan Biotechnology)
was used at 1:500, and incubated at 378C for 1.5 h. Protein bands
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technology, Rockford, IL, USA).
MEIS1 constructs
The complete human MEIS1 coding sequence was isolated by PCR
using neuroblastoma tumor cDNA as a template with forward
primer 50-ccggaattccggATGGCGCAAAGGTACGAC-30 and reverse
primer 50-ccgcgtcgacggCTACTGAGCATGAATGTCCAT-30. The
forward primer consisted of a non-coding ﬂag containing an EcoRI
recognition site (underlined) and the ATG initiation codon (in bold
capitals) followed by codons 2–6 (in capitals), representing nt 458–
475 of the human MEIS1 NCBI RefSeq NM_002398 coding
sequence. The reverse primer consisted of a non-coding ﬂag contain-
ing a SalI recognition site (underlined) and the TAG stopcodon (in
bold capitals) preceded by the ﬁnal codons 385–390 (in capitals),
representing nt 1630–1610 of the NM_002398 coding sequence.
This sequence encoded MEIS1B, the most widely expressed MEIS1
splice variant (see also Geerts et al., 2005 and the MEIS1 locus
in TranscriptView at http://bioinfo.amc.uva.nl/human-genetics/
transcriptviewb/). The derived human MEIS1B protein (NCBI
sequence NP_002389, 390 residues) was identical to mouse Meis1B
protein (NCBI sequence Q60 954), except for substitution of the Ile
residue at position 201 in the human sequence by an analogous Val
residue at position 201 in the mouse sequence. The 1196 bp MEIS1
PCR product was restricted with EcoRI and SalI, puriﬁed by
agarose gel electrophoresis using Qiaex II gel extraction (20021,
Qiagen, Venlo, The Netherlands) and ligated into EcoRI–SalI
restricted pCI-neo vector (E1841, Promega Benelux, Leiden, The
Netherlands) backbone. The MEIS1 sequence was excised from this
construct using EcoRI and the 30 polylinker NotI site and subcloned
into the pcDNA4/TO/myc-HisA mammalian expression vector
(V1030-20, Invitrogen, Breda, The Netherlands) restricted with
EcoRI and NotI, resulting in pcDNA4/MEIS1. The construct was ver-
iﬁed by sequencing, and expression of MEIS1 protein by the construct
was demonstrated by western blot analysis of transiently transfected
HEK293T cells and stably transfected human neuroblastoma cells
(Revet et al., manuscript in preparation, see also Fig. 2 in Geerts
et al., 2005).
The Meis1 siRNA expression constructs were prepared as follows:
oligos T14F 50-gatcccTCCAGAACTGGATAACTTGttcaagagaCA
AGTTATCCAGTTCTGGAtttttggaaa-30 and T14R 50-agcttttccaaaaa
TCCAGAACTGGATAACTTGtctcttgaaCAAGTTATCCAGTTCTG
GAgg-30, targeting the TCAAGAACTGGATAACTTG sequence in
MEIS1 mRNA (nt 871–889 in the human MEIS1 RefSeq
NM_002398, and 862–880 in the murine Meis1 RefSeq
NM_010789) or 16F 50-gatcccCTTGATGATTCAAGCCAT
AttcaagagaTATGGCTTGAATCATCAAGtttttggaaa-30 and 16R
50-agcttttccaaaaaCTTGATGATTCAAGCCATAtctcttgaaTATGGCT-
TGAATCATCAAGgg-30, targeting the CTTGATGATTCAAGC-
CATA sequence in MEIS1 mRNA (nt 886–904 in NM_002398,
and 877–895 in NM_010789) were annealed and ligated into pTER
restricted with BglII and HindIII as described (van de Wetering
et al., 2003), to create pTER/Meis1-T14 and pTER/Meis1-T16,
respectively. A non-targeting pTER construct contained a similar
sequence that had no homology to the human or murine genome,
and was used as a negative control. The constructs were veriﬁed by
sequencing and siRNA-mediated MEIS1 protein and mRNA knock-
down by both constructs was demonstrated (Revet et al., manuscript
in preparation, see also Fig. 2 in Geerts et al., 2005). The T14 and
T16 constructs have complete homology to human MEIS1 as well
as to murine Meis1, and target all annotated MEIS1 splice variants
(i.e. isoforms A-D, see also Geerts et al., 2005).
DNA/liposome preparation
Plasmid DNA (1–2 ml) was mixed with 50 ml Opti-MEM reduced
serum medium (31985, Invitrogen, Carlsbad, CA, USA), added to
4 ml liposome [a 3:1 (w/w) formulation of 2,3-dioleyloxy-
N-[2(sperminecarboxamido)ethyl]-N-N-dimethyl-1- propanaminium
triﬂuoroacetate (DOPSA) and dioleoylphosphatidyl ethanolamine
(DOPE) (11668-027, Invitrogen)] in 50 ml OptiMEM and incubated
for 20 min at room temperature. Final concentrations were 16 mg/
ml DNA and 40 mg/ml liposome.
In vivo gene transfection
Nulliparous female and male Kunming mice of reproductive age were
supplied by Center of Experimental Animals, Tongji Medical College
(Wuhan, China). Female mice were mated and examined every 8 h
until detection of a vaginal plug, which was designated Day 1 of the
pregnancy. The mice were anesthetized 30–60 h following plug
detection with 1% butaylone given by i.p. injection. A laparotomy
was performed to expose the uterus and 25 ml of the DNA/liposome
complex was injected into the base of each uterine horn using a
27-gage needle, as described (Bagot et al., 2000; Hsieh et al.,
2002). The incision was closed in two layers (peritoneal and
cutaneous) with 4–0 vicryl suture. The mice were euthanized by cer-
vical vertebrae dislocation under anesthesia before excision of the
uteri. For the experiments studying the effect of MEIS1 expression
manipulation on MEIS1 expression, litter size and pinopode for-
mation, the group sizes were ﬁve mice each transfected with
pcDNA4/MEIS1, empty pcDNA4, pTER/Meis1 siRNA construct
or non-targeting pTER, respectively (20 mice in total). For the exper-
iments studying the effect of MEIS1 expression manipulation on Itgb3
expression, 25 mice each were transfected with pcDNA4/MEIS1,
empty pcDNA4, pTER/Meis1 siRNA construct or non-targeting
pTER, respectively (100 mice in total). The numbers of mice available
for Meis1 expression analysis in Fig.5 were 19,17, 19 and 19, respect-
ively (the remainder were not pregnant in spite of the detection of the
vaginal plug or died of post-surgical complications). The presented
work conformed to the ‘Guiding principles in the Care and Use of
Animals’ as described in DHEW publication No. (NIH) 85-23,
Revised 1985, Ofﬁce of Science and Health Reports, DRR/NIH,
Bethesda, MD 20982, USA, was approved by the ethical committee
of Tongji Medical College and was also covered by Chinese animal
husbandry legislation.
Scanning electron microscropy
Uteri were dissected from mice 90 h after vaginal plug detection. The
specimens were dehydrated in an acetone series, dried in a critical
point drier using carbon dioxide, mounted on the specimen holder,
coated with gold and examined under a Stereoscan 520 Scanning Elec-
tron Microscope (Hitachi, Tokyo, Japan). From each biopsy, six to
eight tissues fragments, measuring 2 mm in thickness and 10 mm
in length, were evaluated. A minimum of an aggregated 4–5 mm
2
of well-preserved epithelial surface was analyzed, to increase the like-
lihood that the observations were representative by negating the inﬂu-
ence of local differences in endometrial morphology. The evaluations
were performed with coded tissue and read blindly by an experienced
investigator according to Nikas and Makrigiannakis (2003).
Immunohistochemistry
The expression of mouse Itgb3 protein in the uterus was evaluated by
immunohistochemistry using a goat polyclonal antibody to Itgb3
(sc-6626, Santa Cruz). The full-thickness biopsies were obtained at
the time of histological evaluation from each uterine horn. The speci-
mens were embedded in parafﬁn and serial 5 mm sections obtained.
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peroxidase was blocked with 3% H2O2 at room temperature for
10 min. After blocking for 45 min with 1.5% normal horse serum in
PBS, the sections were incubated overnight at 48C with primary
Itgb3 antibody (1:200) in PBS. The sections were then incubated
with biotinylated rabbit anti-goat IgG (ZDR-5308, Zhongshan Bio-
technology) as a secondary antibody at 1:50 and incubated at 378C
for 30 min, subsequently with avidin and biotinylated peroxidase at
room temperature for 45 min, and ﬁnally with DAB (400 mg/ml) at
room temperature for 5 min. Hematoxylin was used for counterstain-
ing. The staining of 100 consecutive cells in ﬁve non-adjacent micro-
scopic ﬁelds was evaluated. Immunoreactivity of Itgb3 was scored as
follows: 1þ, ,25% of cells stained; 2þ, .25% but ,50% of cells
stained; 3þ, .50% but ,75% of cells stained; and 4þ, .75% of
cells stained. Overall intensity was scored as weak (1þ), moderate
(2þ) or strong (3þ). The sum of cell stained scores and intensity
scores was calculated to quantify the expression of Itgb3.
Statistical analysis
All numerical results are expressed as the mean value+SD, except
for the Affymetrix expression values of MEIS1–3 mRNAs in
normal human tissue, which are represented as mean value+SEM.
The data of MEIS1 mRNA in endometrium during the menstrual
cycle were analyzed by analysis of variance. Comparisons between
the expression of Meis1 in each group of murine tissue, Itgb3 in
each group of murine tissue and litter size of each group of mice
were performed using two-tailed unpaired t-tests. The differences of
pinopode development between each group of murine tissue were ana-
lyzed using a chi-square test. P , 0.05 was considered signiﬁcant in
all tests. The Statistical Package for the Social Sciences software
package for Windows (Version 13.0) was used for all statistical
analyses.
Results
Expression of MEIS1, MEIS2 and MEIS3 genes in the
normal human uterus
Affymetrix data for a set of 87 different normal human tissue
types (the ‘human body index’ set) representing a total of
504 tissue samples were retrieved from the NCBI website.
As shown in Fig. 1, MEIS1 was highly expressed in both
uterine tissues present in the data set: myometrium and endo-
metrium. In fact, the MEIS1 expression in these two tissues
was the highest observed in all 87 tissue types investigated.
In contrast, MEIS2 expression was high in myometrium,
although several other tissues show even higher expression,
but only moderate in endometrium. Finally, the MEIS3 gene
showed overall much lower expression (5–7-fold) than the
MEIS1 and MEIS2 genes. The high expression of MEIS1 com-
pared with MEIS2 and MEIS3 in endometrium prompted us to
investigate the expression and function of the MEIS1 gene in
the reproductive cycle.
Expression of MEIS1 mRNA during the human reproductive
cycle
MEIS1 expression has been previously demonstrated in epi-
thelial cells of the developing female reproductive tract (Dintil-
hac et al., 2005). To investigate the expression of MEIS1 in
cyclic development of the endometrium, the menstrual cycle
stage-speciﬁc expression was determined by RT–PCR.
Representative EtBr stained agarose gel pictures of RT–PCR
are shown in Fig. 2. MEIS1 mRNA expression was evident
throughout the menstrual cycle.
To assess potential regulation of MEIS1 expression during
the reproductive cycle, densitometric analysis was performed
on all samples, and the average abundance of MEIS1 during
each stage of the menstrual cycle normalized to GAPDH, cal-
culated. No difference was apparent between the levels of
expression in the segments of the proliferative phase. In con-
trast, expression at the mid secretory phase was elevated rela-
tive to other stages (see legend to Fig. 2). These results were a
ﬁrst indication that MEIS1 expression varied during the men-
strual cycle, markedly increasing at the mid secretory phase
(S2), which corresponded to the time of implantation.
MEIS1 mRNA is expressed in the human endometrial stroma
and glands
To investigate the site of MEIS1 expression in the human endo-
metrium, and as a support of the MEIS1 expression detected
with RT–PCR described above, in situ hybridization was per-
formed. Fig. 3a and b shows high-power views of MEIS1
expression in proliferative and secretory endometrium.
MEIS1 was expressed in both glandular and stromal cells.
This supports the results of RT–PCR in Fig. 2, and further
suggests that MEIS1 may play a role in embryonic
implantation.
Down-regulation of Meis1 expression affects murine embryo
implantation rate
To assess whether an up-regulation of Meis1 expression during
embryo implantation was essential to this process, the
expression of maternal Meis1 was down-regulated in a
mouse model by transfection in vivo, as described by (Bagot
et al., 2000; Hsieh et al., 2002). A ﬁrst indication of decreased
Meis1 expression in the uterus was obtained by RT–PCR, and
this was conﬁrmed by western blot on Day 3 after transfection.
Representative results for mRNA are shown in Fig. 4a and
b. Densitometric analysis was performed on all samples, and
the average abundance of Meis1 mRNA in each group normal-
ized to b-actin mRNA was calculated. Levels of Meis1 mRNA
and protein (Fig. 4b and c) were signiﬁcantly decreased in
endometrium transfected with pTER/Meis1 siRNA compared
with the control.
At Day 9 of pregnancy, mice were killed and the uteri
removed and examined for normal histology and for the
number of implantation sites per uterus as a measure of litter
size. The endometrium appeared histologically normal, and
demonstrated adequate decidualization. Also the total number
of pregnant mice did not vary signiﬁcantly between Meis1
siRNA-treated mice and the control. Pups of mice transfected
with Meis1 siRNA were born following a normal length ges-
tation of 18–22 days, were of normal size and demonstrated
no morphological abnormalities. However, the average
number of implantation sites per uterus was 12.2+1.5 in the
mice transfected with the control pTER plasmid and 7.6+
2.7 in the mice transfected with a pTER/Meis1 siRNA con-
struct (Fig. 5a). Decreased expression of Meis1 therefore
resulted in a signiﬁcant decrease in litter size (see legend to
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Visual representation of MEIS1, MEIS2 and MEIS3 expression in the ‘human body index’ Affymetrix data set in the public domain: 504 samples
representing 87 different normal human tissues. For reasons of presentation, only tissues consisting of ﬁve or more different samples were shown:
40 tissues representing 329 samples. MEIS1 expression in endometrium and myometrium was higher than in any of the non-shown sets. Average
MEIS expression in all 87 tissues was: MEIS1 338.3, MEIS2 516.6 and MEIS3 77.1. For comparison: average expression of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) and b-actin in this data set was 9240 and 11 890, respectively. Average MEIS gene expression in endome-
trium (18 samples) was: MEIS1 1241+83, MEIS2 358+99 and MEIS3 149+16. Average MEIS expression in myometrium (27 samples) was:
MEIS1 1330+90, MEIS2 1273+84 and MEIS3 254+26. The average expression over the different samples per tissue is shown. The error bars
represent the SEM
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up-regulation of Meis1 in the reproductive cycle contributes
to normal embryo implantation.
To evaluate the effect of up-regulation of Meis1 expression
in the adult murine uterus, mice were transfected with the
pcDNA4/MEIS1 expression construct, or with empty
pcDNA4 plasmid (as a negative control). A ﬁrst indication of
increased Meis1 expression in the uterus was obtained by
RT–PCR and this was conﬁrmed by western blot. Levels of
Meis1 mRNA and protein were signiﬁcantly increased in endo-
metrium transfected with the pcDNA4/MEIS1 expression con-
struct compared with the control (Fig. 4c and d). As in the
experiment described above, uterine histology was not affected
by the transfection, and the number of mice pregnant and the
weight and morphology of the pups did not differ between
the groups. The average number of implantation sites was
13.4+1.1 in the pcDNA4/MEIS1 treated mice and 12.6+
1.1 in the control mice (Fig. 5b). In contrast to Meis1 down-
regulation, up-regulation of Meis1 expression by pcDNA4/
MEIS1 treatment did not signiﬁcantly alter litter size.
Effect of Meis1 on murine pinopode formation
For further clues as to a possible function for Meis1 in murine
implantation, uterine epithelial morphology was investigated.
As described above, no uterine histological changes could be
detected at the light microscopy level in mice transfected
with Meis1 DNA constructs. To evaluate the effect of Meis1
on epithelial morphology, the uteri of these mice were
examined with scanning electron microscopy for evidence of
altered formation of pinopodes.
Mice which were transfected in vivo as described above were
killed 4.5 days after vaginal plug detection, the uteri removed
and prepared for electron microscopy analysis. ***Fig. 6a and
b shows a typical section of endometrium from a pcDNA4/
MEIS1-treated mouse, and an empty pcDNA4-treated control
mouse; there was a signiﬁcant increase in the development of
pinopodes in the mouse transfected with MEIS1 over-
expression plasmid. Fig. 6c and d shows a typical section of
endometrium from pTER/Meis1 and control pTER-treated
mouse uteri. None of the sections from Meis1 siRNA-treated
mice contained normal pinopodes. The secretory cells were
covered with dense microvilli, instead of with pinopodes, and
were slightly bulging. In contrast, all sections from control
animals contained a normal number of pinopodes. Apparently,
decreasing Meis1 expression had a negative effect on efﬁcient
pinopode maturation. Absence of a normal amount of function-
ing pinopods in mice transfected with Meis1 siRNA could be a
mechanism contributing to a less efﬁcient embryonic implan-
tation rate and diminished litter size in these animals.
Effect of Meis1 on Itgb3 expression in the murine uterus
Maternal Hoxa10 has earlier been shown to be involved in
pinopode formation in the mouse uterus (Bagot et al., 2001),
in a manner resembling the effect of Meis1 on pinopode for-
mation observed in this study. To investigate a possible con-
nection between Meis1 and Hoxa10 function in murine
uterine development and embryonic implantation, we evalu-
ated the effect of Meis1 expression manipulation on Itgb3
expression. To obtain a ﬁrst indication of differential Itgb3
mRNA expression, peri-implantation uteri from mice treated
with pcDNA4/MEIS1 or empty pcDNA4 (as a negative
control), or with pTER/Meis1 or non-targeting pTER (as a
negative control) were analyzed by RT–PCR. Fig. 7a shows
a representative EtBr gel picture of the RT–PCR. Densito-
metric analysis was performed on all samples, and the
average abundance of Itgb3 in each group normalized to
Figure 2: MEIS1 mRNA expression in human endometrium during
the menstrual cycle.
RT–PCR analysis of MEIS1 expression. A representative agarose gel
stained with ethidium bromide (EtBr) picture is shown. MEIS1 was
expressed in all stages of the human menstrual cycle investigated;
the ﬁrst half of the proliferative phase (P1), the second half of the pro-
liferative phase (P2) and the ﬁrst third of the secretory phase (S1), the
mid-secretory phase (S2) and the late secretory phase (S3). The
sample numbers for the P1, P2, S1, S2 and S3 groups were 5, 7, 7,
8 and 6, respectively. M, size markers. No PCR product was observed
in control samples that did not contain RT enzyme during RT syn-
thesis or template DNA during PCR (not shown). RT–PCR analysis
was repeated at least three times per sample. MEIS1 expression was
analyzed by densitometry and normalized to GAPDH in 33 endo-
metrial samples. The densitometric analysis was repeated three
times, with similar results. The data were analyzed using analysis of
variance. The average MEIS1/GAPDH ratio in each group was: P1
0.20+0.02, P2 0.26+0.03, S1 0.41+0.07, S2 0.70+0.10 and S3
0.44+0.09. There was no statistical difference within the prolifera-
tive phase (P ¼ 0.47), but the difference between the proliferative
phase and the secretory phase was signiﬁcant (P ¼ 0.00001)
Figure 3: MEIS1 mRNA expression in human endometrial tissue.
In situ hybridization analysis of MEIS1 expression in human endo-
metrial samples. Views of two representative samples demonstrate
MEIS1 expression in both the glandular and stromal cells of (a) pro-
liferative phase and (b) secretory phase endometrium. MEIS1
mRNA is stained brown. No staining was observed when the
MEIS1 probe was omitted (not shown). Scale bar ¼ 100 mm. Each
sample was analyzed at least in triplicate
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niﬁcantly decreased in endometrium transfected with pTER/
Meis1 siRNA compared with the control. In contrast, levels
of Itgb3 mRNA increased in endometrium transfected with
the pcDNA4/MEIS1 expression construct compared with the
control (see legend to Fig. 7).
To support the results of the RT–PCR described above, the
effect of Meis1 expression on Itgb3 protein levels was deter-
mined by immunohistochemistry on transfected uterine tissue
of each group. Representative pictures are shown in Fig. 7b.
Itgb3 expression levels appeared higher in mice transfected
with pcDNA4/MEIS1 expression construct compared with
the pcDNA4 control. In contrast, Itgb3 expression was lower
in mice transfected with Meis1 siRNA expression constructs
than in those transfected with the non-targeting siRNA con-
struct. Statistic analysis of the Itgb3 immunoreactivity was per-
formed on the samples, and the average abundance of Itgb3 in
each group was calculated. Levels of Itgb3 expression were
signiﬁcantly decreased in endometrium transfected with
pTER/Meis1 siRNA compared with the control. In contrast,
Itgb3 protein levels were increased in endometrium transfected
with the pcDNA4/MEIS1 expression construct compared with
the control (see legend to Fig. 7). This was consistent with the
results of the RT–PCR.
Together, these results showed that, in a murine uterine
receptivity model, the expression of the known Hoxa10
target Itgb3 could be regulated by the manipulation of Meis1
expression, suggesting Meis1 action through co-operation, or
possibly interaction, with Hoxa10.
Discussion
HOXA10 is essential for normal embryonic uterine develop-
ment. In the developing mouse embryo, altered Hoxa10
expression as a result of targeted mutation (Satokata et al.,
1995) or exposure to diethylstilbestrol leads to abnormal
uterine development (Block et al., 2000). Hoxa10 expression
persists in the adult uterus and is important for implantation
of the embryo. Hoxa10 null-mutant mice or mice in which
Hoxa10 has been blocked using antisense oligonucleotides
demonstrate decreased litter size due to failure of implantation
(Benson et al., 1996; Bagot et al., 2000).
HOX genes function as transcription factors and either acti-
vate or repress target genes. The pleiotropic effects of
Figure 4: Meis1 expression manipulation in murine uterine tissue.
(a) RT–PCR analysis of Meis1 expression in 20 murine endometria transfected with pcDNA4/MEIS1, Meis1 small interfering RNA (siRNA)
constructs or respective controls (ﬁve animals in each group). Shown is a representative EtBr picture. (b) Meis1 mRNA expression was analyzed
by densitometry and normalized to b-actin as described in Fig. 2, except that data were analyzed using a two-tailed unpaired t-test. No PCR
product was observed in control samples that did not contain RT enzyme during RT synthesis or template DNA during PCR (not shown).
RT–PCR and quantiﬁcation was repeated at least three times, with similar results. Average Meis1/b-actin ratios in endometrium transfected
with pcDNA4/MEIS1 (U) and control pcDNA4 DNA (Uc) were 0.90+0.09 and 0.48+0.07, respectively. There was a signiﬁcant increase
in Meis1mRNA in the up-regulationgroup (U) compared withthe control (Uc) (P ¼ 0.0001). AverageMeis1/b-actin levelin endometriumtrans-
fected with Meis1 siRNA (D) and control pTER constructs (Dc) were 0.27+0.05 and 0.40+0.03, respectively. Levels of Meis1 mRNA were
signiﬁcantly decreased in Meis1 siRNA-transfected samples (D) compared with the control samples (Dc) (P ¼ 0.002). (c) Western analysis per-
formed on 20 murine endometria transfected with pcDNA4/MEIS1, Meis1 siRNA or respective controls (ﬁve animals in each group). A repre-
sentative western blot image is shown. (d) Meis1 protein expression was analyzed by densitometry and normalized to b-actin values as described
in Fig. 4b. No Meis1 band was detected on western blot in the absence of primary Meis1 antiserum (not shown). Western blot analysis and quanti-
ﬁcation was repeated at least three times, with similar results. The average Meis1/b-actin ratio in each group was: U 0.94+0.05, Uc 0.57+0.06,
D 0.37+0.05 and Dc 0.57+0.08. There was a signiﬁcant increase in Meis1 protein in endometria transfected with pcDNA4/MEIS1 (U) com-
pared with pcDNA4-transfected controls (Uc) (P ¼ 0.00001). Endometria transfected with pTER/Meis1 siRNA constructs (D) demonstrated a
signiﬁcant decrease in Meis1 protein compared with pTER controls (Dc) (P ¼ 0.01)
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modulated through the regulation of multiple downstream
targets that are necessary for the implantation process
(Daftary et al., 2002; Troy et al., 2003). HOXA10 has been
demonstrated to be involved in the regulation of pinopode
development and expression of other genes involved in endo-
metrial development such as ITGB3 and EMX2 (Bagot et al.,
2001; Daftary et al., 2002; Troy et al., 2003).
HOX proteins require co-operation with other proteins to
bind to their target DNA. MEIS1 in particular aids 50 HOX pro-
teins, like HOXA10, to gain this speciﬁcity. MEIS1 physically
interacts with 50 HOX proteins HOXA9–11 by forming hetero-
dimeric binding complexes on a DNA target containing a
MEIS1 site (TGACAG) and an Abd-B-like Hox site
(TTTTACGAC) (Shen et al., 1997). Studies demonstrated
that MEIS1 gene and HOXA9-13 genes are co-expressed
throughout Mu ¨llerian duct differentiation (Dintilhac et al.,
2005), which suggests that MEIS1 might play a role in embryo-
nic female genital tract development. We have performed data-
mining on Affymetrix gene expression database in the public
domain showing that MEIS1 was highly expressed in human
endometrium as well as in myometrium (Fig. 1), implying it
may play a role in reproductive function in the adult human
uterus.
We therefore investigated the expression pattern of the
MEIS1 gene at different stages of the human menstrual
cycle, demonstrating that MEIS1 appeared to be expressed in
the endometrium at different levels, depending on the men-
strual cycle stage. MEIS1 mRNA levels appeared signiﬁcantly
increased in the mid secretory phase, closely resembling the
expression pattern of HOXA10. This observation pointed to
the possibility that MEIS1 is an active cofactor of HOXA10
in the human endometrium.
On the basis of the results described above, we postulated
that Meis1 and Hoxa10 might have closely related roles in ver-
tebrate reproduction and in the regulation of endometrial cell
proliferation or differentiation. Meis1 null-mutant mice die
between embryonic days 11.5 and 14.5, because of internal
hemorrhage, liver hypoplasia and anemia (Azcoitia et al.,
2005). The embryo lethal phenotype has precluded investi-
gation of the function of Meis1 in the adult reproductive tract
of Meis1 mutant mice. Therefore, to investigate the role of
Meis1 in adult reproductive function in a mouse model, we
altered the expression of the Meis1 gene in the adult murine
endometrium. When mouse endometrium was transfected
with Meis1 siRNA at the time of implantation, the number of
embryos that could implant in the uterus was reduced by
40%. This signiﬁcant reduction in implantation sites demon-
strated that, in normal embryonic development, optimal
implantation beneﬁts from maternal Meis1 expression.
We also investigate the effect of Meis1 on pinopodes. Pino-
pode formation is directly regulated by HOXA10 (Bagot et al.,
2001). In this study, we examined whether the expression of
pinopodes could be also affected by altering Meis1 expression
levels. We demonstrated that blocking Meis1 expression
reduced pinopode numbers and reduced their ability to differ-
entiate into fully mature forms. In contrast, supernumerary
pinopodes could be induced by over-expression of Meis1.
To elucidate potential mechanisms by which Meis1 might
control endometrial function and receptivity to the implanting
blastocyst, we tested the effect of altering Meis1 expression on
Itgb3 expression. The ITGB3 gene has been identiﬁed as the
ﬁrst known target of HOXA10 gene regulation in the endome-
trium (Daftary et al., 2002). As a bridging molecule between
the endometrium and trophoblast (Kiefer et al., 1989; Van
Dijk et al., 1993; Sueoka et al., 1997), ITGB3 plays an import-
ant role in embryonic implantation. We found that a blockade
of Meis1 expression with Meis1 siRNA was associated with a
decrease in Itgb3 mRNA. Itgb3 mRNA levels signiﬁcantly
increased after up-regulation of Meis1 expression with
MEIS1 cDNA. It appeared likely that Itgb3 was not regulated
by Hoxa10 monomer, but by a heterodimeric or heterotrimeric
transcription complex containing Meis1. The interaction of
Abd-B-like HOX transcription factors and MEIS1 at the
HOX site in the target gene promoter has been demonstrated
in myeloid differentiation. The co-activation of HOXA9 and
MEIS1 is a common event in AML (Lawrence et al., 1999;
Camo ´s et al., 2006), but co-regulation of MEIS1 and
HOXA9, and also of HOXA10, might play a role in pathogen-
esis of acute lymphocytic and acute myeloid leukemias associ-
ated with ALL-1 fusions (Rozovskaia et al., 2001; Ferrando
et al., 2003; Dik et al., 2005). In addition, Pineault et al.
Figure 5: Effect of Meis1 expression on mouse litter size.
Litter size, as determined by counting the number of implantation sites
per uterus examined, at Day 9 of pregnancy. Mice were transfected 1
day after detection of a vaginal plug with pTER/Meis1, control pTER,
pcDNA4/MEIS1 or empty pcDNA4. (a) Litter size was reduced by
40% in the group of mice transfected with pTER/Meis1 siRNA com-
pared with pTER controls. This difference was statistically signiﬁcant
according to a two-tailed unpaired t-test (P ¼ 0.00001). (b) Litter size
at Day 9 of gestation was not affected by transfection with pcDNA4/
MEIS1 compared with pcDNA4-transfected controls (P ¼ 0.08). The
experiment was repeated three times, with similar results
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HOXA10 rearrangement releasing HOX expression necessary
for leukemia induction. Finally, binding of MEIS1 to
HOXA10 could be demonstrated in vitro (Williams et al.,
2005).
CDKN1A (also known as P21 or CIP1) is a transcriptional
target of HOXA10 in differentiating myelomonocytic cells.
CDKN1A reporter expression is enhanced after transfection
with PBX1 and HOXA10, especially when MEIS1 was
co-transfected (Bromleigh and Freedman, 2000). It is likely
that a similar regulation occurs with HOXA10 and MEIS1
cofactor in the endometrium. Recently, Taylor et al. have con-
ﬁrmed that this potential protein–protein interaction does
occur in endometrial cells. Ablation of the PBX cofactor half-
site results in a loss of HOXA10–PBX2 binding to the EMX2
probe, suggesting the importance of the PBX2/HOXA10
protein–protein interaction in endometrium for high afﬁnity
HOXA10 binding to its target genes (Sarno et al., 2005).
In conclusion, this study shows for the ﬁrst time that MEIS1
expression contributes to endometrial receptivity in mouse.
MEIS1 can function in cancer as an inhibitor of differentiation,
andhaveapositiveinﬂuenceoncellularproliferation(see‘Intro-
duction’). In addition, the MEIS genes are potent enhancers of
early cell proliferation during development (reviewed in
Geerts et al., 2003, 2005). MEIS1 could have a similar
proliferative function during endometrial development. The
Figure 6: Effect of Meis1 expression on murine pinopode formation.
Pinopode development in transfected mouse uteri, examined with scanning electron microscopy. (a) Transfection with pcDNA4/MEIS1 demon-
strated fully developed pinopodes on most ( 60%) secretory cells. (b) Transfection with empty pcDNA4 plasmid as a negative control showed a
wide distribution of developing pinopodes, covering 50% of the endometrial luminal surface. However, there was a much lower occurrence
(20%) of fully developed pinopodes in this group. (c) Transfection with Meis1 siRNA plasmid resulted in the majority of the endometrial
surface expressing few, to no, pinopodes. Instead, the epithelial cells were covered with short and thick microvilli. (d) Transfection with non-
targeting pTER plasmid as a control resulted in developing pinopodes on about half of the secretory cells. Scale bar ¼ 10 mm. The experiment
was repeated three times. The data were analyzed using a chi-square test
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1403expression pattern of MEIS1, its contribution to pinopode
formation in mouse and its effect on Itgb3 expression suggest
that the effects of MEIS1 on endometrial function occur
through affecting the afﬁnity and speciﬁcity of HOXA10–
DNA interactions, leading to the regulation of downstream
targets of HOXA10. The identiﬁcation of MEIS1 as a potential
HOXA10co-operatinggenecouldleadtoelucidationofapartial
HOXA10 network in endometrial development, but could also
establish MEIS1 in a signaling network in its own right.
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